Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MG-115 (Z-LL-Nva-CHO) is a potent and reversible inhibitor of proteasome , with K i s of 21 nM and 35 nM for 20S and 26S proteasome, respectively. MG-115 specifically inhibit the chymotrypsin-like activity of the proteasome, induces p53-dependent apoptosis [1] [2] [3].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 222.00 | |
10 mg | In stock | $ 355.00 | |
25 mg | In stock | $ 468.00 | |
50 mg | In stock | $ 572.00 | |
100 mg | In stock | $ 913.00 |
Description | MG-115 (Z-LL-Nva-CHO) is a potent and reversible inhibitor of proteasome , with K i s of 21 nM and 35 nM for 20S and 26S proteasome, respectively. MG-115 specifically inhibit the chymotrypsin-like activity of the proteasome, induces p53-dependent apoptosis [1] [2] [3]. |
In vitro | MG-115 (0.1-10 μM; 24 h) decreases the viability of HepG2 cells in a dose-dependent manner [3]. MG-115 (0.1-10 μM; 24 h) amplifies the reporter gene expression mediated by CWK 18 DNA condensates [3]. Cell Viability Assay [3] Cell Line: HepG2 cells Concentration: 0.1, 1, 2, 5, 10 μM Incubation Time: 24 hours Result: Dose-dependently decreased cell viability. Inhibited the proteasomal activity, with an IC 50 of 2 μM. |
Synonyms | Z-LL-Nva-CHO |
Molecular Weight | 461.59 |
Formula | C25H39N3O5 |
CAS No. | 133407-86-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45mg/mL (97.5mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MG-115 133407-86-0 Proteases/Proteasome Ubiquitination Proteasome MG115 MG 115 Z-LL-Nva-CHO inhibitor inhibit